Forte Biosciences, Inc. (NASDAQ:FBRX) is held by 35 institutional investors per 13F filings through June 2024.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 31 Dec, 2025 | 1,765,516 | 130,136 | 7.96% | $48,145,621.00 |
| Federated Hermes, Inc. | 31 Dec, 2025 | 1,765,516 | 130,136 | 7.96% | $48,145,621.00 |
| Federated Hermes, Inc. | 31 Dec, 2025 | 1,765,516 | 130,136 | 7.96% | $48,145,621.00 |
| Federated Hermes, Inc. | 31 Dec, 2025 | 1,765,516 | 130,136 | 7.96% | $48,145,621.00 |
| Federated Hermes, Inc. | 31 Dec, 2025 | 1,765,516 | 130,136 | 7.96% | $48,145,621.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Dec, 2025 | 1,460,971 | -175,059 | -10.70% | $39,840,679.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Dec, 2025 | 1,460,971 | -175,059 | -10.70% | $39,840,679.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Dec, 2025 | 1,460,971 | -175,059 | -10.70% | $39,840,679.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Dec, 2025 | 1,460,971 | -175,059 | -10.70% | $39,840,679.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Dec, 2025 | 1,460,971 | -175,059 | -10.70% | $39,840,679.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,425,785 | 21,943 | 1.56% | $39,159,185.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,425,785 | 21,943 | 1.56% | $39,159,185.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,425,785 | 21,943 | 1.56% | $39,159,185.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,425,785 | 21,943 | 1.56% | $39,159,185.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 1,425,785 | 21,943 | 1.56% | $39,159,185.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 1,196,955 | 0 | 0.00% | $32,640,963.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 1,196,955 | 0 | 0.00% | $32,640,963.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 1,196,955 | 0 | 0.00% | $32,640,963.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 1,196,955 | 0 | 0.00% | $32,640,963.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 1,196,955 | 0 | 0.00% | $32,640,963.00 |